- Home
- INMB vs PAVM Comparison
INMB vs PAVM Comparison
Compare INMB & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | PAVM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | 21 | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 43.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | INMB | PAVM |
|---|---|---|
| Price | $1.64 | $5.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.40 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 1.2M | 13.2K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $0.21 |
| 52 Week High | $3.24 | $28.44 |
Technical Indicators
Market Signals| Indicator | INMB | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 40.84 |
| Support Level | $1.23 | $4.50 |
| Resistance Level | $1.76 | $6.56 |
| Average True Range (ATR) | 0.17 | 0.54 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 16.00 | 18.40 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.